NEW YORK (GenomeWeb News) – Rosetta Genomics has terminated a licensing deal with Chinese diagnostic firm Avatao Biotech, the Israeli molecular diagnostic firm disclosed in a document filed with the US Securities and Exchange Commission on Monday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.
Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.
A startup company is offering a test to analyze soil samples from farms for pathogens.
Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.